A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(R) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) as Initial Treatment of Patients With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Sonus Pharmaceuticals
- 16 Nov 2008 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov .
- 24 Sep 2007 Status change from in progress to discontinued.
- 19 Aug 2005 New trial record.